In today’s briefing:
- Lepu Biopharma (乐普生物科技) IPO: Sentiment Cooled Down
Lepu Biopharma (乐普生物科技) IPO: Sentiment Cooled Down
- Lepu Biopharma is a biotech spin-off of A-share listed Lepu Medical. The company launched book building to raise up to USD 120m via a Hong Kong listing.
- In our previous note, we look at the company’s core products, including HX008, LP002, MRG003 and MRG002. The products have their own differentiating factors to tackle the intense competition.
- In this note, we provide an update for the book building. We will run the deal through our ECM framework and provide an update on the deal.
Before it’s here, it’s on Smartkarma
